CRBU

Caribou Biosciences, Inc.

CIK 0001619856 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)

$1.94

↑ 0.00 (0.00%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Options; Risks: Fundamentals

Key stats

Market Cap

$192.41M

P/E Ratio

-1.44

EPS

-1.59

Dividend Yield

Not covered

52W Position

26%

Beta

2.42

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

1.89

P/S

17.17

EV/Revenue

16.10

ROE

-130.6%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 26%

$1.38$3.54

Latest Financials

2025-12-31 FY

Revenue

$11.16M

Net Income

-$148.13M

Total Assets

$175.37M

Free Cash Flow

-$112.35M

CRBU

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

CRBU

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news